1,123例术前68Ga-PSMA PET/CT与mpMRI对比全包埋前列腺根治病理研究
该回顾性研究纳入1,123例术前行mpMRI和68Ga-PSMA PET/CT后接受机器人辅助腹腔镜前列腺根治术的男性,比较两种影像单独及联合预测肿瘤位置和Gleason评分≥3+4的能力。结果显示两者对index病灶和多灶肿瘤检出率相似,联合可识别92%的index Gleason评分≥3+4癌;活检Gleason≤3+4且SUVmax<5者仅10%升级为≥4+3,而SUVmax>11者90%升级。
要点
- mpMRI与68Ga-PSMA PET/CT对index病灶及多灶肿瘤检出率相似。
- 两者联合可识别92%的index Gleason评分≥3+4前列腺癌。
- 活检Gleason≤3+4且SUVmax<5者仅10%升级为≥4+3,SUVmax>11者90%升级。
核心结论
- 在mpMRI基础上增加诊断性68Ga-PSMA PET/CT可提高显著前列腺癌的检出并改善筛选适合主动监测男性的能力。
研究设计与样本
- 回顾性纳入1,123例术前行mpMRI和68Ga-PSMA PET/CT后接受机器人辅助腹腔镜前列腺根治术的男性,比较影像与全包埋前列腺病理。
主要发现
- mpMRI与68Ga-PSMA PET/CT对index病灶和多灶肿瘤检出率相似(p=0.10;p=0.11)。
- 联合mpMRI与68Ga-PSMA PET/CT可识别92%的index Gleason评分≥3+4癌。
- 活检Gleason评分≤3+4且SUVmax<5者仅10%升级为≥4+3,SUVmax>11者90%升级。
- 中位前列腺特异性抗原为6,活检和根治病理中位Gleason评分均为4+3。
临床怎么用
- 对mpMRI后仍存疑的显著前列腺癌风险者,可考虑加做68Ga-PSMA PET/CT辅助定位和风险分层。
- 活检低级别且SUVmax<5者可支持主动监测筛选,SUVmax>11者应警惕升级风险。
局限性
- 回顾性设计,仅纳入接受机器人辅助腹腔镜前列腺根治术的男性,存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Multiparametric magnetic resonance imaging (mpMRI) fails to identify some men with significant prostate cancer. Prostate-specific membrane antigen positron emission tomography/computerized tomography (PSMA PET/CT) is recommended for staging of prostate cancer, but its additional benefit above mpMRI alone in local evaluation for prostate cancer is unclear. The study aim was to evaluate the ability of mpMRI and PSMA PET/CT individually and in combination, to predict tumor location and Gleason score ≥3+4 on robot-assisted laparoscopic radical prostatectomy (RALP) histology. MATERIALS AND METHODS: We retrospectively reviewed 1,123 men with a preoperative mpMRI and 68Ga-PSMA PET/CT prior to a RALP. Tumor locations were collected from both imaging modalities and compared to totally embedded prostate histology. Lowest apparent diffusion coefficient value on mpMRI and the highest maximum standardized uptake value (SUVmax) on 68Ga-PSMA PET/CT were collected on the index lesions to perform analysis on detection rates. RESULTS: Median prostate specific antigen was 6. Median Gleason score on biopsy and RALP histology was 4+3. The index lesion and multifocal tumor detection were similar between mpMRI and 68Ga-PSMA PET/CT (p=0.10; p=0.11). When combining mpMRI and 68Ga-PSMA PET/CT, index Gleason score ≥3+4 cancer at RALP was identified in 92%. Only 10% of patients with Gleason score ≤3+4 on biopsy with an SUVmax <5 were upgraded to ≥4+3 on RALP histology, compared to 90% if the SUVmax was >11. CONCLUSIONS: The addition of a diagnostic 68Ga-PSMA PET/CT to mpMRI can improve the detection of significant prostate cancer and improve the ability to identify men suitable for active surveillance.
引用
- Raveenthiran S, Yaxley WJ, Franklin T, et al. Findings in 1,123 Men with Preoperative 68Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography and Multiparametric Magnetic Resonance Imaging Compared to Totally Embedded Radical Prostatectomy Histopathology: Implications for the Diagnosis and Management of Prostate Cancer. J Urol. 2021. PMID: 34694140. doi:10.1097/JU.0000000000002293
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。